In the following video, Motley Fool health-care analyst David Williamson takes a question from a Fool reader, who asks, "Should I buy, sell or hold Teva Pharmaceutical Industries Limited (TEVA 2.89%)?"
Read Next
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Stocks Mentioned
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.